Kirjoita osake tai kryptovaluutta hakupalkkiin saadaksesi yhteenvedon
UMP Healthcare Holdings Ltd
0722UMP Healthcare Holdings Limited, an investment holding company, provides a range of medical and healthcare services in Hong Kong, Macau, and Mainland China. It operates in three segments, Hong Kong & Macau Corporate Healthcare Solution Services, Hong Kong & Macau Clinical Healthcare Services, and Mainland China Clinical Healthcare Services. The company offers general practice and family medicine; specialist consultation services, including internal medicine, surgery, pediatrics, cardiology, dermatology, otorhinolaryngology, orthopedics, ophthalmology, urology, gastroenterology and hepatology, radiology, endocrinology, and diabetes; and dental care services, such as dental implant, cosmetic dentistry, periodontal treatments, and orthodontics, as well as traditional Chinese medicines. It also provides physiotherapy services comprising muscle-strengthening, limb function, eye-hand coordination, and hand function trainings; day surgery and endoscopy; diagnostic imaging and laboratory; preventive medicines and health assessment; visa medical examination; vaccination and consultation; vision care and optometry; plastic, head, and neck surgeries; medical and cosmetics dermatology, and aesthetics; chronic disease management, such as hypertension, cardiovascular disease, diabetes, and joint diseases; and corporate healthcare solutions and third party administration services. In addition, the company offers WeWell Healthcare, a health service platform for family health management, recommending, and arranging professional medical and health services for each family member, including health checkup, vaccinations, and other specialist medical services referrals, etc. Further, it provides specialist consultation services. It serves insurance companies and corporations, and self-paid patients. The company was founded in 1990 and is headquartered in Central, Hong Kong. Address: Wing On House, Central, Hong Kong
Analytics
WallStreetin tavoitehinta
18.76 HKDP/E-suhde
8.6Osinkotuotto
7.67 %Kuluva vuosi
Edellinen vuosi
Nykyinen vuosineljännes
Viimeinen vuosineljännes
Kuluva vuosi
Edellinen vuosi
Nykyinen vuosineljännes
Viimeinen vuosineljännes
Avainluvut 0722
Osinkoanalytiikka 0722
Osinkojen kasvu 5 vuoden aikana
62 %Jatkuva kasvu
7 vuottaMaksusuhde 5 vuoden keskiarvo
86 %Osinkohistoria 0722
Osakkeen arvostus 0722
Talousasiat 0722
Tuloksia | 2019 | Dynamiikka |